The first major rewrite of the guidelines since 2015 was published September 28, 2026, in Veterinary Dermatology by the International Committee on Allergic Diseases of Animals. The authors reorganized the guidance around how each therapy works and where it fits in the course of disease, rather than around how quickly it acts. Therapies are sorted by mechanism of action, care is split into reactive and proactive phases, and guidance on two newer Janus kinase inhibitors is included.
Source: DVM 360, November 2, 2026. Link.
Related: New owner questionnaire tracks canine atopic dermatitis signs between appointments, DVM 360, November 2, 2026. Link.
Leave a Reply